Florida bladder cancer trends 1981 to 2004: Minimal progress in decreasing advanced disease

Journal of Urology

Volumn 179, Issue 2, 2008, Pages 491-495

  Nieder, Alan M ^a   MacKinnon, Jill A ^a   Huang, Youjie ^a   Fleming, Lora E ^a   Koniaris, Leonidas G ^a   Lee, David J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder; Bladder neoplasms; Diagnosis; Mass screening; Mortality

Indexed keywords

ADVANCED CANCER; AFRICAN AMERICAN; ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; DEMOGRAPHY; FEMALE; HISPANIC; HUMAN; MALE; PRIORITY JOURNAL; UNITED STATES; BLADDER TUMOR; CAUCASIAN; INCIDENCE; PATHOLOGY; REGISTER; SEX RATIO; STATISTICS; SURVIVAL RATE;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLORIDA; HISPANIC AMERICANS; HUMANS; INCIDENCE; MALE; NEOPLASM STAGING; REGISTRIES; SEX DISTRIBUTION; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 38849172641     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.09.082     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al: Cancer statistics, 2006. CA Cancer J Clin 2006;56:106.
2. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S et al: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 2001;19:666.
3. Nieder AM, John S, Messina CR, Granek IA and Adler HL: Are patients aware of the association between smoking and bladder cancer? J Urol 2006;176:2405.
4. Mansson A, Anderson H and Colleen S: Time lag to diagnosis of bladder cancer-influence of psychosocial parameters and level of health-care provision. Scand J Urol Nephrol 1993;27:363.
5. Mommsen S, Aagaard J and Sell A: Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol 1983;17:163.
6. Araki M, Nieder AM, Manoharan M, Yang Y and Soloway MS: Lack of progress in early diagnosis of bladder cancer. Urology 2007;69:270.
7. Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC et al: Cancer surveillance series: interpreting trends in prostate cancer-part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999;91:1017.
8. Jhaveri FM, Klein EA, Kupelian PA, Zippe C and Levin HS: Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. J Clin Oncol 1999;17:3167.
9. Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC et al: A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000;164:1768.
10. Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, Friedrich MG, Ekici S, Huland H et al: A side by side comparison of cytology and biomarkers for bladder cancer detection. J Urol 2004;172:1123.
11. Toma MI, Friedrich MG, Hautmann SH, Jakel KT, Erbersdobler A, Hellstern A et al: Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer. World J Urol 2004;22:145.
12. Zeegers MP, Kellen E, Buntinx F and van den Brandt PA: The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004;21:392.
13. Zeegers MP, Goldbohm RA and van den Brandt PA: A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control 2002;13:83.
14. Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R et al: Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 1989;44:622.
15. Chacko JA, Heiner JG, Siu W, Macy M and Terris MK: Association between marijuana use and transitional cell carcinoma. Urology 2006;67:100.
16. Nieder AM, Lipke MC and Madjar S: Transitional cell carcinoma associated with marijuana: case report and review of the literature. Urology 2006;67:200.
17. Lotan Y, Svatek RS and Sagalowsky AI: Should we screen for bladder cancer in a high-risk population? A cost per lifeyear saved analysis. Cancer 2006;107:982.
18. Breslow RA, Sorkin JD, Frey CM and Kessler LG: Americans' knowledge of cancer risk and survival. Prev Med 1997;26:170.
19. Zhu SH, Anderson CM, Tedeschi GJ, Rosbrook B, Johnson CE, Byrd M et al: Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med 2002;347:1087.